DTIL

PRECISION BIOSCIENCES INC

—

Insider Sentiment

Last purchase: 2026-09-28
Last sale: 2026-02-18
Shares purchased (TTM): 11,825
Shares sold (TTM): 113,001

Buy ratio (TTM)9.5%

Institutional Sentiment

As of: 2026-06-30
Institutional shares owned: 17,467,820
Shares outstanding: 25,856,628
Ownership: 67.56%

+29.91% Y/Y

Earnings Market Reaction

Filing date: 2026-08-06
Price on filing date: —
1-month reaction: 4.85%
3-month reaction: Pending

Drift continued5/11 (45%)

Faded / reversed6/11 (55%)

Export data

Recent filings

10-Q2026-06-30Filed 2026-08-06
10-Q2026-03-31Filed 2026-05-05
10-K2025-12-31Filed 2026-03-12
10-Q2025-09-30Filed 2025-11-03
10-Q2025-06-30Filed 2025-08-07
10-Q2025-03-31Filed 2025-05-15
10-K2024-12-31Filed 2025-03-26
10-Q2024-09-30Filed 2024-11-04
10-Q2024-06-30Filed 2024-08-01
10-Q2024-03-31Filed 2024-05-13
10-K2023-12-31Filed 2024-03-27
10-Q2023-09-30Filed 2023-11-07

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

Balance Sheet

Values in millions ($)

Line item	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets Current
Cash And Cash Equivalents At Carrying Value	86	99	111	45	62	77	86	99	124	138	117	122
Accounts Receivable Net Current	0	4	0	0	0	0	0	0	0	0	1	4
Marketable Securities Current	1	2	5	0	0	-	0	2	-	-	-	-
Prepaid Expense Current	4	4	3	6	7	5	6	7	6	9	6	8
Notes And Loans Receivable Net Current	-	-	-	-	-	-	-	-	12	12	12	12
Assets Held For Sale Not Part Of Disposal Group Current	-	-	0	0	0	0	0	0	0	0	0	-
Other Assets Current	0	0	0	1	0	0	0	0	1	0	0	0
Assets Current	92	109	119	52	70	82	95	111	144	161	136	146
Restricted Cash And Cash Equivalents	26	26	26	26	23	23	23	23	-	-	-	-
Property Plant And Equipment Net	1	1	1	2	2	3	3	4	4	5	6	9
Intangible Assets Net Excluding Goodwill	1	1	1	1	1	1	1	0	0	0	0	1
Operating Lease Right Of Use Asset	5	5	6	6	6	7	7	7	8	8	8	1
Equity Securities F V N I Noncurrent	1	1	1	1	1	3	3	3	3	3	3	2
Notes Receivable Net	-	-	0	5	6	6	5	5	6	7	5	6
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Assets	126	144	154	94	109	124	136	153	166	185	160	164
Liabilities Current
Accounts Payable Current	1	1	0	1	1	1	1	1	1	1	3	1
Employee Related Liabilities Current	2	1	5	3	2	1	5	4	2	1	5	4
Contract With Customer Liability Current	-	-	0	6	6	6	3	0	1	2	12	17
Loans Payable Current	-	-	-	-	-	-	-	-	22	22	22	22
Operating Lease Liability Current	2	2	2	1	1	1	1	1	1	1	1	1
Other Liabilities Current	1	1	1	1	1	1	1	1	2	3	2	2
Liabilities Of Disposal Group Including Discontinued Operation Current	-	-	0	1	1	1	1	1	1	2	3	2
Liabilities Current	7	8	9	15	14	12	15	12	33	33	50	51
Loans Payable	22	22	22	22	22	22	22	22	-	-	-	-
Contract With Customer Liability Noncurrent	-	-	0	20	20	21	23	27	27	75	73	74
Operating Lease Liability Noncurrent	4	4	5	5	6	6	6	7	7	7	8	-
Business Combination Contingent Consideration Liability	10	10	10	10	10	10	10	10	10	10	10	10
Other Liabilities Noncurrent	0	0	0	0	0	0	0	0	-	-	0	1
Liabilities Of Disposal Group Including Discontinued Operation Noncurrent	-	-	-	-	-	-	-	-	-	-	0	-
Liabilities	81	68	62	77	75	75	80	88	91	148	141	135
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	-	0	-	-	-	-	-
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	626	624	621	566	562	553	540	531	524	519	509	503
Retained Earnings Accumulated Deficit	-579	-547	-528	-548	-527	-503	-482	-465	-448	-481	-490	-473
Treasury Stock Value	-1	-1	-1	-1	-1	-1	-1	-1	-1	-1	-1	-1
Stockholders Equity	45	76	92	17	34	49	56	65	75	37	19	29
Liabilities And Stockholders Equity	126	144	154	94	109	124	136	153	166	185	160	164
Preferred Stock Par Or Stated Value Per Share	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	26	26	24	12	12	11	8	8	7	7	4	4
Shares Outstanding	26	26	24	12	12	11	8	7	7	7	4	4

Select a line item above to chart it.

Recent filings

10-Q2026-06-30Filed 2026-08-06
10-Q2026-03-31Filed 2026-05-05
10-K2025-12-31Filed 2026-03-12
10-Q2025-09-30Filed 2025-11-03
10-Q2025-06-30Filed 2025-08-07
10-Q2025-03-31Filed 2025-05-15
10-K2024-12-31Filed 2025-03-26
10-Q2024-09-30Filed 2024-11-04
10-Q2024-06-30Filed 2024-08-01
10-Q2024-03-31Filed 2024-05-13
10-K2023-12-31Filed 2024-03-27
10-Q2023-09-30Filed 2023-11-07

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

PRECISION BIOSCIENCES INC (DTIL) — SEC Financial Statements & Analysis

PRECISION BIOSCIENCES INC (DTIL) is a biological products, (no diagnostic substances) company, incorporated in DE. PRECISION BIOSCIENCES INC trades on Nasdaq as: DTIL. PRECISION BIOSCIENCES INC (DTIL)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, PRECISION BIOSCIENCES INC carries a market cap of $203.23M, a P/E ratio of -3.85x, a P/B ratio of 4.49x, a P/S ratio of 4.51x, an enterprise value of $90.83M, and an EV/EBITDA multiple of -2.58x. On profitability, it posts a gross margin of 103.05%, an operating margin of -80.78%, a net margin of -117.04%, a Return on Equity (ROE) of -132.91%, and a Return on Assets (ROA) of -44.91%. Per share, it reports EPS of $-2.04, diluted EPS of $-2.04, free cash flow per share of $-2.01, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 3472.96% year-over-year, net income growth of -32.62% year-over-year, and EPS growth of -71.21% year-over-year. On the balance sheet, it maintains a current ratio of 12.82x, a quick ratio of 12.26x, working capital of $84.41M, a debt-to-equity ratio of 1.78x, a debt ratio of 0.64, an interest coverage ratio of -10.49x, free cash flow of $-51.94M (TTM), and net debt of $-112.41M. Figures sourced from SEC EDGAR.

Market Cap: $203.23M
P/E TTM: -3.85x
EPS TTM: $-2.04
P/B TTM: 4.49x
ROE TTM: -132.91%
ROA TTM: -44.91%
Debt To Equity: 1.78x
Free Cash Flow TTM: $-51.94M
Net Revenue TTM Growth 1Y: 3472.96%

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is PRECISION BIOSCIENCES INC in?

PRECISION BIOSCIENCES INC (DTIL) operates in the Biological Products, (No Diagnostic Substances) industry.

What exchange does DTIL trade on?

PRECISION BIOSCIENCES INC (DTIL) trades on the Nasdaq.

Where is PRECISION BIOSCIENCES INC incorporated?

PRECISION BIOSCIENCES INC is incorporated in DE.

When was PRECISION BIOSCIENCES INC (DTIL)'s most recent SEC filing?

PRECISION BIOSCIENCES INC (DTIL)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06.

What is DTIL's market cap?

PRECISION BIOSCIENCES INC (DTIL) has a market capitalization of $203.23M as of 2026-06-30.

What is DTIL's EPS (earnings per share)?

PRECISION BIOSCIENCES INC (DTIL)'s trailing twelve month EPS is $-2.04 as of 2026-06-30.

What is DTIL's ROE (return on equity)?

PRECISION BIOSCIENCES INC (DTIL)'s trailing twelve month Return on Equity (ROE) is -132.91% as of 2026-06-30.

What is DTIL's ROA (return on assets)?

PRECISION BIOSCIENCES INC (DTIL)'s trailing twelve month Return on Assets (ROA) is -44.91% as of 2026-06-30.

What is DTIL's EV/EBITDA?

PRECISION BIOSCIENCES INC (DTIL)'s trailing twelve month EV/EBITDA is -2.58x as of 2026-06-30.

Wall Street's data.
Main Street's price.

Start 7-day free trial

DTIL

Company Information

Insider Sentiment

Institutional Sentiment

Earnings Market Reaction

Recent filings

Recent filings

PRECISION BIOSCIENCES INC (DTIL) — SEC Financial Statements & Analysis

Frequently Asked Questions

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.